期刊文献+

念珠菌生物被膜和抗真菌研究新进展 被引量:1

下载PDF
导出
摘要 随着广谱抗菌药的广泛使用、化疗、器官移植手术以及AIDS和免疫缺陷患者增多,真菌感染的发生率正逐年上升,真菌耐药性的产生也日益严重。念珠菌是人类主要的真菌病原体,引起黏膜及深部组织感染,研究表明,生物被膜的形成是真菌耐药性形成的重要机制之一,研究新型抗真菌药物和新的治疗方法已成为国内外研究的热点。本文主要从念珠菌生物被膜的形成及耐药、抗念珠菌生物被膜药物、以及新的抗真菌治疗方法(包括从天然植物中提取抗菌的有效成分、使用银纳米粒子,抗念珠菌抗体,以及光动力治疗等)几个方面分析和总结抗念珠菌治疗的研究现状和发展前景。
作者 肖萍
出处 《药物流行病学杂志》 CAS 2013年第6期328-331,共4页 Chinese Journal of Pharmacoepidemiology
  • 相关文献

参考文献26

  • 1Rajendran R, Robertson DP, Hodge PJ, et al. Hydrolyti- cenzyme production is associated with Candida albicans bio- film formation from patientswith type 1 diabetes [ J ]. Myco- pathologia , 2010,170:229-235.
  • 2Kuhn DM, Ghannoum MA. Candida biofilms: antifungal re- sistance and emerging therapeutie options [ J ]. Curr Opin Investig Drugs, 2004,5 : 186-197.
  • 3Rautemaa R, Ramage G. Oral eandidosis-clinieal challenges of a biofilm disease [ J ]. Crit Rev Microbiol, 2011,37 : 328- 336.
  • 4Lewis K. Multidrug tolerance of biofilms and persister cells [J]. Curr Top Microbiol hnmunol,2008,322:107-131.
  • 5Bink A, Vandenbosch D, Coenye T, et al. Superoxide dis- mutases are involved in Candida albicans biofihn persistence againstmiconazole [ J ]. Antimicrob Agents Chemother, 2011 , 55:4033-4037.
  • 6Ramage G, Rajendran R, Shen'y L, et al. Fungal biofilm re- sistance[J]. Int J Microbiol, 2012, 528-521.
  • 7Fauvart M,De Groote VN,Michiels J. RoLe of persister cells in chronic infections:clinical relevance and perspectives on anti-persister therapies [ J ]. J Med Microbio1,2011 , 60:699- 709.
  • 8Senevi,'atne C J, Wang Y, Jin L,et aL Candida alhieans bio- film formation is associated with increased anti-oxidative ca- paci-ties [J]. Proteomics,2008, 8(14):2936-2947.
  • 9Nett JE, Sanchez H, Cain MT, et al. Interface of Candidaal- bicans biofilm matrix-associated drug resistance and cell wall integrity regulation [ J ]. Eukaryot Cell, 2011,10 : 1660- 1669.
  • 10Mattiuzzi G, Giles FJ. Management of intracranial fungal in- fections in patients with haematological malignancies [ J ]. Br J Haematol , 2005,131 : 287-300.

同被引文献15

  • 1王爱平,余进,万喆,陈伟,刘维达,李岷,沈永年,李春阳,苏英,曾凡钦,席丽艳,张军民,李希清,鲁长明,赖维,黄怀球,于浩,娄冬华,万苗坚,张玉清,李若瑜.1%硝酸异康唑乳膏治疗体股癣、足癣疗效和安全性评价[J].中国真菌学杂志,2007,2(4):225-228. 被引量:3
  • 2Veraldi S. Isoconazole nitrate: a unique broad-spectrum antimicmbial azole effective in the treatment of dermatomyeoses, both as monothempy and in combination with corticosteroids [ J ]. Mycoses, 2013, 56 Suppl 1: 3-15.
  • 3Fromfling RA. Overview of medically important antifungal azole deriva- tives[J]. Clin Microbiol Rev, 1988, 1(2) : 187-217.
  • 4Vanden BH, Matiehal P. Mode of action of anti-Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors [ J ]. Am J Ob- stet Gynecol, 1991, 165(4 Pt 2) : 1193-1199.
  • 5Odds FC, Cheesman SL, Abbott AB. Suppression of ATP in Candida albieans by imidazole and derivative antifungal agents [ J ]. Sabourau- dia, 1985, 23(6) : 415-424.
  • 6Moulin-Traffort J, Venot C, Regli P. Action of isoconazole on Candida albicans. Study by scanning and transmission electron microscopy[J]. Pathol Biol (Paris), 1986, 34(8) : 899-907.
  • 7Wosicka H, Cal K. Targeting to the hair follicles: current status and potential[J]. J Dermatol Sci, 2010, 57(27 : 83-89.
  • 8Lademann J, Patzelt A, Schanzer S,et al. Non-invasive analysis of pen- etration and storage of Isoconazole nitrate in the stratum comeum and the hair follicles[ J]. Eur J Pharm Biopharm, 2012, 80(3) : 615-620.
  • 9Czaika VA, Siebenbreck J, Czekalla F,et al. Reactive oxygen species and the bacteriostatic and bactericidal effects of isoconazole nitrate [ J ]. Mycoses, 2013, 56 Suppl 1:16-22.
  • 10Tauber U. Availability of isoconazole in human skin after dermal appli- cation as free base and as nitrate in vitro [ J ]. Arzneimittelforschung, 1987, 37(4) : 461-463.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部